Clinical Trials Browser

Withdrawn × Leiomyoma × telapristone acetate × Clear all

NCT00874302 2014-06-27

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

Phase 3 Withdrawn

Leiomyoma